MedPath

盘锦恒昌隆药业有限公司

Ownership
-
Established
2002-01-09
Employees
-
Market Cap
-
Website
http://www.hclyy.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

NMPA:26

Drug Approvals

Diclofenac Sodium Enteric-coated Tablets

Product Name
双氯芬酸钠肠溶片
Approval Number
国药准字H21023775
Approval Date
Jul 13, 2020
NMPA

熊胆胶囊

Approval Number
国药准字Z21021104
Approval Date
Jul 13, 2020
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H21022059
Approval Date
Jul 13, 2020
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H21021518
Approval Date
Jul 13, 2020
NMPA

Compound Diclofenac Sodium and Chlorphenamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H21022560
Approval Date
Jul 13, 2020
NMPA

Oxytetracycline Hydrochloride Tablets

Product Name
盐酸土霉素片
Approval Number
国药准字H21023987
Approval Date
Jul 13, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H21023986
Approval Date
Jul 13, 2020
NMPA

康尔心胶囊

Approval Number
国药准字Z21021099
Approval Date
Jun 15, 2020
NMPA

银翘解毒片

Approval Number
国药准字Z21021105
Approval Date
Jun 15, 2020
NMPA

感冒退热颗粒

Approval Number
国药准字Z21021097
Approval Date
Jun 15, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.